StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

3-(4-(4-Chlorophenyl)cyclohexyl)-4-hydroxynaphthalene-1,2-dione

HCID 74989
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
137732-39-9
Standard-SMILES
O=C1C(=O)c2ccccc2C(O)=C1C1CCC(c2ccc(Cl)cc2)CC1
InChIKey
BSJMWHQBCZFXBR-UHFFFAOYSA-N
Summenformel
C22H19ClO3
Durchschnittliche Molmasse
366,8 g/mol
Monoisotopische Masse
366,1022722

Überblick

Atovaquone is a naphthoquinone compound having a 4-(4-chlorophenyl)cyclohexyl group at the 2-position and a hydroxy substituent at the 3-position. It has a role as an antifungal agent, an antimalarial, an EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor, an EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor and an EC 1.10.2.2 (quinol--cytochrome-c reductase) inhibitor. It is a hydroxy-1,4-naphthoquinone and a member of monochlorobenzenes.

Namen und Bezeichner

Bevorzugter Name
3-(4-(4-Chlorophenyl)cyclohexyl)-4-hydroxynaphthalene-1,2-dione
IUPAC
3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione
Englischer Name
cis-Atovaquone
Summenformel
C22H19ClO3
Molmasse
366.84

Namen und Synonyme

3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dioneDTXSID209166943-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxynaphthalene-1,2-dioneRefChem:1066764DTXCID20888847630-425-2ATOVAQUONE95233-18-4MepronWellvonecis-AtovaquoneAcuvel
Weitere Namen anzeigen
cis-Atovaquone-d4Atovaquone EP Imp BAtovaquone Impurity 17Atovaquone EP Impurity B (RC A)Atovaquone Impurity 2(Atovaquone EP Impurity B)Atovaquone EP Impurity B (Atovaquone Related Compound A)Atovaquone EP Impurity B (Atovaquone USP Related Compound A)
137732-39-9Atavaquone94015-53-9566C80Mepron (antipneumocystic)CIS-ATOVAQUONE (RACEMIC)Atovaquone EP Impurity BBW 566C

Datenbank-Bezeichner

CAS
137732-39-9、94015-53-9、95233-18-4

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
5,2
Polarare Oberfläche (TPSA)
54,4 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
2
Schwere Atome
26
Formalladung
0
Komplexität
595

Experimentelle und physikochemische Eigenschaften

Drugs · 3 Einträge

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Used in Switzerland

Pharmaceuticals

LogP5.07
SolubilityPractically insoluble
Collision Cross Section174.53 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
40 °C · >40°C (dec.)
Siedepunkt
535 · 535.0±50.0 °C(Predicted)
Dichte
1.349 · 1.349±0.06 g/cm3(Predicted)
storage temp.
Room Temperature, under inert atmosphere
Löslichkeit
Chloroform (Slightly), Dichloromethane (Slightly, Acetonitrile)
pka
5.01 · 5.01±0.10(Predicted)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Gefahrenhinweise

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

Sicherheitsdaten

wgk
3
Speicherklasse
11 - Combustible Solids

Chemie und Industrie

Pharmakologische Informationen

ATC CodeP01AX06
Protein BindingAtovaquone is extensively bound to plasma proteins (99.9%) over the concentration range of 1 to 90 µg/mL.
Pharmacodynamics · 1 Eintrag

Atovaquone is a highly lipophilic drug that closely resembles the structure [ubiquinone]. Its inhibitory effect being comparable to ubiquinone, atovaquone can act by selectively affecting mitochondrial electron transport and parallel processes such as ATP and pyrimidine biosynthesis in atovaquone-responsive parasites. Cytochrome bc1 complex (complex III) seems to serve as a highly discriminating molecular target for atovaquone in Plasmodia. There is no significant risk for myelosuppression associated with atovaquone, making this drug a beneficial therapeutic agent for recipients of bone marrow transplantation.

Mechanism of Action · 1 Eintrag

The mechanism of action against <i>Pneumocystis carinii</i> has not been fully elucidated. In Plasmodium species, the site of action appears to be the cytochrome bc1 complex (Complex III). Several metabolic enzymes are linked to the mitochondrial electron transport chain via ubiquinone. Inhibition of electron transport by atovaquone will result in indirect inhibition of these enzymes. The ultimate metabolic effects of such blockade may include inhibition of nucleic acid and ATP synthesis. Atovaquone also has been shown to have good <i>in vitro</i> activity against <i>Toxoplasma gondii</i>.

Biological Half-Life2.2 to 3.2 days
Metabolism/MetabolitesSome evidence suggests limited metabolism (although no metabolites have been identified).
Absorption, Distribution and Excretion · 4 Einträge

The bioavailability of atovaquone is low and variable and is highly dependent on formulation and diet. Bioavailability of the suspension increases two-fold when administered with meals. When administered with food, bioavailability is approximately 47%. Without food, the bioavailability is 23%.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
PubChem CID
74989
DTXSID
DTXSID20916694
ChEMBL
CHEMBL471792、CHEMBL519462
ChEBI
CHEBI:575568
UNII
F1W7QUV0KI、Y883P1Z2LT
EC Number
689-795-9
Nikkaji
J1.549.967B、J389.528I
Aggregatzustand
Solid
Farbe
Pale Yellow to Light Yellow
Major Application
pharmaceutical (small molecule)

The half-life of atovaquone is long due to presumed enterohepatic cycling and eventual fecal elimination. There was little or no excretion of atovaquone in the urine (less than 0.6%).

0.60 ± 0.17 L/kg

10.4 +/- 5.5 ml/min [HIV-infected patients receiving IV administration]

Anwendungen

Verwendencis-Atovaquone is the cis-isomer of Atovaquone (A793500), a hydroxynaphthoquinone derivative that inhibits mitochondrial electron transport.